SPDL1 and pancreatic ductal adenocarcinoma: Using in-house IHC and bioinformatic exploration of public datasets, Klimaszewska–Wiśniewska et al. [13] found that high levels of SPDL1 protein were linked to an improved outcome in pancreatic ductal adenocarcinoma.